{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T20:59:56Z","timestamp":1780952396713,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T00:00:00Z","timestamp":1684627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T00:00:00Z","timestamp":1684627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncol Ther"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s40487-023-00232-9","type":"journal-article","created":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T12:01:12Z","timestamp":1684670472000},"page":"303-312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth Interviews"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2031-3035","authenticated-orcid":false,"given":"Todd J.","family":"Bixby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Brittle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Mangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Stadtmauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Kallenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,21]]},"reference":[{"issue":"suppl 1","key":"232_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/jha2.338","volume":"3","author":"S Sengsayadeth","year":"2022","unstructured":"Sengsayadeth S, Savani BN, Oluwole O, Dholaria B. Overview of approved CAR-T therapies, ongoing clinical trials, and its impact on clinical practice. EJHaem. 2022;3(suppl 1):6\u201310.","journal-title":"EJHaem"},{"issue":"suppl 1","key":"232_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood-2021-146032","volume":"138","author":"R Cusatis","year":"2021","unstructured":"Cusatis R, Tan I, Piehowski C, et\u00a0al. Worsening financial toxicity among patients receiving chimeric antigen receptor T-cell (CAR-T) therapy: a mixed methods longitudinal study [abstract]. Blood. 2021;138(suppl 1):567.","journal-title":"Blood"},{"issue":"13 suppl","key":"232_CR3","first-page":"S253","volume":"27","author":"R Borgert","year":"2021","unstructured":"Borgert R. Improving outcomes and mitigating costs associated with CAR T-cell therapy. Am J Manag Care. 2021;27(13 suppl):S253\u201361.","journal-title":"Am J Manag Care"},{"key":"232_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1200\/OP.22.00315","volume":"18","author":"J Mikhael","year":"2022","unstructured":"Mikhael J, Fowler J, Shah N. Chimeric antigen receptor T-cell therapies: barriers and solutions to access. JCO Oncol Pract. 2022;18:800\u20137.","journal-title":"JCO Oncol Pract"},{"key":"232_CR5","unstructured":"Leukemia & Lymphoma Society. Chimeric antigen receptor (CAR) T-cell therapy. 2022. https:\/\/www.lls.org\/treatment\/types-treatment\/immunotherapy\/chimeric-antigen-receptor-car-t-cell-therapy. Accessed 21 April 2022."},{"key":"232_CR6","unstructured":"U.S. Food and Drug Administration. KYMRIAH (tisagenlecleucel). 2021. https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/kymriah-tisagenlecleucel. Accessed 21 April 2022."},{"key":"232_CR7","unstructured":"U.S. Food and Drug Administration. TECARTUS (brexucabtagene autoleucel). 2022. https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/tecartus-brexucabtagene-autoleucel. Accessed 21 April 2022."},{"key":"232_CR8","unstructured":"U.S. Food and Drug Administration. YESCARTA (axicabtagene ciloleucel). 2022. https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/yescarta-axicabtagene-ciloleucel. Accessed 21 April 2022."},{"key":"232_CR9","unstructured":"U.S. Food and Drug Administration. CARVYKTI. 2022. https:\/\/www.fda.gov\/vaccines-blood-biologics\/carvykti. Accessed 21 April 2022."},{"key":"232_CR10","unstructured":"U.S. Food and Drug Administration. ABECMA (idecabtagene vicleucel). 2021. https:\/\/www.fda.gov\/vaccines-blood-biologics\/abecma-idecabtagene-vicleucel. Accessed 21 April 2022."},{"key":"232_CR11","unstructured":"U.S. Food and Drug Administration. BREYANZI (lisocabtagene maraleucel). 2021. https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/breyanzi-lisocabtagene-maraleucel. Accessed 21 April 2022."},{"key":"232_CR12","unstructured":"CAR-T Cell Science. Defining CAR T associated toxicities. 2022. https:\/\/www.cartcellscience.com\/car-t-associated-toxicities\/. Accessed 21 April 2022."},{"key":"232_CR13","unstructured":"Shaw G. Hospitals still grappling with $1 M+ price tag for CAR-T Rx. Pharmacy Practice News. 2021. https:\/\/www.pharmacypracticenews.com\/Clinical\/Article\/10-21\/Hospitals-Still-Grappling-With-1-M-Price-Tag-for-CAR-T-Rx\/64913?ses=ogst. Accessed 21 April 2022."},{"issue":"3","key":"232_CR14","doi-asserted-by":"publisher","DOI":"10.5812\/sdme.67670","volume":"14","author":"M Naderifar","year":"2017","unstructured":"Naderifar M, Goli H, Ghaljaie F. Snowball sampling: a purposeful method of sampling in qualitative research. Strides Dev Med Educ. 2017;14(3): e67670.","journal-title":"Strides Dev Med Educ"},{"key":"232_CR15","first-page":"364","volume":"12","author":"S Carrasco","year":"2021","unstructured":"Carrasco S. Patients\u2019 communication preferences around cancer symptom reporting during cancer treatment: a phenomenological study. J Adv Pract Oncol. 2021;12:364\u201372.","journal-title":"J Adv Pract Oncol"},{"key":"232_CR16","first-page":"342","volume":"11","author":"AL Bryant","year":"2020","unstructured":"Bryant AL, Chan Y-N, Richardson J, Foster M, Owenby S, Wujcik D. Understanding barriers to oral therapy adherence in adults with acute myeloid leukemia. J Adv Pract Oncol. 2020;11:342\u20139.","journal-title":"J Adv Pract Oncol"}],"container-title":["Oncology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40487-023-00232-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40487-023-00232-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40487-023-00232-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T16:19:49Z","timestamp":1692807589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40487-023-00232-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,21]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["232"],"URL":"https:\/\/doi.org\/10.1007\/s40487-023-00232-9","relation":{},"ISSN":["2366-1070","2366-1089"],"issn-type":[{"value":"2366-1070","type":"print"},{"value":"2366-1089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,21]]},"assertion":[{"value":"24 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}